Rostam Namdari

581 total citations
18 papers, 434 citations indexed

About

Rostam Namdari is a scholar working on Immunology, Molecular Biology and Pharmacology. According to data from OpenAlex, Rostam Namdari has authored 18 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 5 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in Rostam Namdari's work include Aquaculture disease management and microbiota (6 papers), Pharmaceutical and Antibiotic Environmental Impacts (4 papers) and Pain Mechanisms and Treatments (3 papers). Rostam Namdari is often cited by papers focused on Aquaculture disease management and microbiota (6 papers), Pharmaceutical and Antibiotic Environmental Impacts (4 papers) and Pain Mechanisms and Treatments (3 papers). Rostam Namdari collaborates with scholars based in Canada, United States and Germany. Rostam Namdari's co-authors include F. C. P. Law, Soheila Abedini, Nicola Price, Robin Sherrington, Simon N. Pimstone, Charles J. Cohen, Michael R. Hayden, Teresa Smith, James J. Price and Agop Y. Bedikian and has published in prestigious journals such as Neurology, Pain and Aquaculture.

In The Last Decade

Rostam Namdari

18 papers receiving 410 citations

Peers

Countries citing papers authored by Rostam Namdari

Since Specialization

Citations

This map shows the geographic impact of Rostam Namdari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rostam Namdari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rostam Namdari more than expected).

Fields of papers citing papers by Rostam Namdari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rostam Namdari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rostam Namdari. The network helps show where Rostam Namdari may publish in the future.

Co-authorship network of co-authors of Rostam Namdari

This figure shows the co-authorship network connecting the top 25 collaborators of Rostam Namdari. A scholar is included among the top collaborators of Rostam Namdari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rostam Namdari. Rostam Namdari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Azetukalner, a Novel K_V7 Potassium Channel Opener, in Adults With Major Depressive Disorder 2025 ·JAMA Network Open ·(unknown), (unknown), Maurizio Fava, Christoph U. Correll, Anthony J. Rothschild, James W. Murrough, Sanjay J. Mathew, Gregory N. Beatch, Celene Grayson, Cynthia L. Harden, (unknown), Joe McIntosh, Rostam Namdari, (unknown)	1
2	Pharmacokinetics of XEN496, a Novel Pediatric Formulation of Ezogabine, Under Fed and Fasted Conditions: A Phase 1 Trial 2022 ·Neurology and Therapy ·Rostam Namdari, (unknown), (unknown), (unknown), Gregory N. Beatch	2
3	Species selection for nonclinical safety assessment of drug candidates: Examples of current industry practice 2021 ·Regulatory Toxicology and Pharmacology ·Rostam Namdari, Keith Jones, Samuel S. Chuang, Steven Van Cruchten, (unknown), Noel Downes, Lars Friis Mikkelsen, (unknown), Sven Jäckel, Björn Jacobsen, Jacqueline Kinyamu-Akunda, (unknown), (unknown), Susanne Mohr, Michael Schmitt, Helen Prior	33
4	A Phase 1 Study to Assess the Safety, Tolerability and Pharmacokinetics of Two Formulations of a Novel Nav1.6 Sodium Channnel Blocker (XEN901) in Healthy Adult Subjects. (4757) 2020 ·Neurology ·Gregory N. Beatch, Rostam Namdari, (unknown), (unknown), Ernesto Aycardi	2
5	Pharmacokinetic and Food Effect Assessment of XEN496 (Pediatric Formulation of Ezogabine) in Healthy Adults and Relative Bioavailability Assessment with Potiga® (Adult Formulation of Ezogabine) (4918) 2020 ·Neurology ·(unknown), Rostam Namdari, Gregory N. Beatch, Ernesto Aycardi	1
6	Safety and Efficacy of a Topical Sodium Channel Inhibitor (TV-45070) in Patients With Postherpetic Neuralgia (PHN) 2016 ·Clinical Journal of Pain ·Nicola Price, Rostam Namdari, (unknown), (unknown), (unknown), (unknown), Michael R. Fetell, Richard Malamut, Robin Sherrington, Simon N. Pimstone, (unknown)	51
7	REVIEW ARTICLE: FAUNISTIC SURVEY AND DISTRIBUTION OF WATER MITES (ACARI: HYDRACHNIDA) IN KHORRAMABAD DISTRICT 2014 ·Rostam Namdari, R Vafaei Shoushtari, Jahanshir Shakarami	1
8	Discovery of thiazolylpyridinone SCD1 inhibitors with preferential liver distribution and reduced mechanism-based adverse effects 2013 ·Bioorganic & Medicinal Chemistry Letters ·Shaoyi Sun, Zaihui Zhang, (unknown), (unknown), (unknown), Rostam Namdari, Kuldip Khakh, Leslie G. Ratkay, David G. McLaren, (unknown), Jianmin Fu, Suzie A. Ferreira, Brian K. Hubbard, Michael D. Winther, Natalie A. Dales	9
9	Human Mendelian pain disorders: a key to discovery and validation of novel analgesics 2012 ·Clinical Genetics ·Y. Paul Goldberg, (unknown), Rostam Namdari, Nicola Price, Charles J. Cohen, (unknown), Michael R. Hayden	27
10	Treatment of Nav1.7-mediated pain in inherited erythromelalgia using a novel sodium channel blocker 2011 ·Pain ·(unknown), Nicola Price, Rostam Namdari, Charles J. Cohen, (unknown), Conrad Winters, James J. Price, Clint E. Young, (unknown), Robin Sherrington, Simon N. Pimstone, Michael R. Hayden	108
11	Pharmacokinetics and Urinary Excretion of Vincristine Sulfate Liposomes Injection in Metastatic Melanoma Patients 2006 ·The Journal of Clinical Pharmacology ·Agop Y. Bedikian, (unknown), Teresa Smith, Susan L. Campbell, Rostam Namdari	47
12	605 Encapsulation of vinorelbine in sphingomyelin/cholesterol liposomes enhances the tumor exposure and antitumor activity of vinorelbine in human mammary and non-small cell lung cancer solid tumor models 2004 ·European Journal of Cancer Supplements ·Sean C. Semple, (unknown), Zheng Yuan, Marianne Eisenhardt, Robert D. Leone, Heather Sweet, Preet Dhaliwal, Rostam Namdari, (unknown), Sandra K. Klimuk	1
13	A comparative tissue distribution study of oxytetracycline in rainbow trout,Oncorhynchus mykiss(Walbaum), and chinook salmon,Oncorhynchus tshawytscha(Walbaum) 1999 ·Aquaculture Research ·Rostam Namdari, Soheila Abedini, F. C. P. Law	23
14	Comparative pharmacokinetics and bioavailability of oxytetracycline in rainbow trout and chinook salmon 1998 ·Aquaculture ·Soheila Abedini, Rostam Namdari, F. C. P. Law	50
15	Tissue Distribution and Elimination of Oxytetracycline in Sea-Pen Cultured Chinook Salmon,Oncorhynchus tshawytscha, and Atlantic Salmon,Salmo salar, Following Medicated-Feed Treatment 1998 ·Journal of Applied Aquaculture ·Rostam Namdari, Soheila Abedini, L. J. Albright, F. C. P. Law	14
16	An oxytetracycline residue depletion study to assess the physiologically based pharmokinetic (PBPK) model in farmed Atlantic salmon. 1997 ·PubMed ·(unknown), Rostam Namdari, F. C. P. Law	17
17	Tissue distribution and elimination of oxytetracycline in seawater chinook and coho salmon following medicated-feed treatment 1996 ·Aquaculture ·Rostam Namdari, Soheila Abedini, F. C. P. Law	37
18	Toxicokinetics of waterborne pyrene in rainbow trout (Oncorhynchus mykiss) following branchial or dermal exposure 1996 ·Aquatic Toxicology ·Rostam Namdari, F. C. P. Law	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact